Najważniejsze publikacje:

1. TP10-Dopamine Conjugate as a Potential Therapeutic Agent in the Treatment of Parkinson’s Disease.
   Rusiecka I, Ruczyński J, Kozłowska A, Backtrog E, Mucha P, Kocić I, Rekowski P.
   Bioconjug Chem. 2019 Mar 20;30(3):760-774. doi: 10.1021/acs.bioconjchem.8b00894. Epub 2019 Jan 31.
2. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals.
   Pawłowska I, Pawłowski L, Krzyżaniak N, Kocić I.
   BioDrugs. 2019 Apr;33(2):183-191. doi: 10.1007/s40259-019-00341-w.
   Select item 30824786 3.
3. Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin.
   Ruczyński J, Rusiecka I, Turecka K, Kozłowska A, Alenowicz M, Gągało I, Kawiak A, Rekowski P, Waleron K, Kocić I.
   Sci Rep. 2019 Mar 1;9(1):3247. doi: 10.1038/s41598-019-40103-w.
4. Rusiecka I, Ruczyński J, Alenowicz M, Rekowski P, Kocić I.Transportan 10 improves the anticancer activity of cisplatin.
   Naunyn Schmiedebergs Arch Pharmacol. 2016 May;389(5):499.
5. Neuroprotective effect of masitinib in rats with postischemic stroke.
   Kocic I, Kowianski P, Rusiecka I, Lietzau G, Mansfield C, Moussy A, Hermine O, Dubreuil P.
   Naunyn Schmiedebergs Arch Pharmacol. 2014 Oct 26. [Epub ahead of print]
6. Cell-penetrating peptides modulate the vascular action of phenylephrine.
   Kocić I, Ruczyński J, Szczepańska R, Olkowicz M, Parfianowicz B, Rusiecka I, Rekowski P.
   Pharmacol Rep. 2011;63(1):195-9.
7. Mortality in hypertensive patients with coronary heart disease depends on chronopharmacotherapy and dipping status.
   Sobiczewski W, Wirtwein M, Gruchała M, Kocić I.
   Pharmacol Rep. 2014 Jun;66(3):448-52. doi: 10.1016/j.pharep.2013.12.009. Epub 2014 Apr 2.
8. Kocić Ivan, Sztormowszka Katarzyna. Pulmonary hypertension modifies responsiveness of sinoatrial cells of rat hearts to adrenomimetics and activators of ATP-sensitive K+ channels in a gender-dependent way. J Physiol Pharmacol 2009; vol. 60, nr 1, s. 165-169.
9. Antiplatelet effect of statins is augmented in diabetic rabbits.
   Kocić I, Racek-Król B, Wapniarska I, Rusiecka I, Wasilewski R, Bitel M.
   Pharmacol Rep. 2010 Mar-Apr;62(2):410-3.
10. Estrogen-induced relaxation of the rat tail artery is attenuated in rats with pulmonary hypertension.
    Kocić I, Szczepańska R, Wapniarska I.
    Pharmacol Rep. 2010 Jan-Feb;62(1):95-9.
11. Polecamy naszą publikację dotyczącą nowe leki wpływające na kanały potasowe i stosowane w Kardiologii, Diabetologii, Pulmonologii i neurologii.
    http://benthamscience.com/ebooks/9781608052356/index.htm
12. Aspartimide modified galanin analogue antagonizes galanin action on insulin secretion.
    Ruczyński J, Konstański Z, Cybal M, Kocić I, Rekowski P.
    Protein Pept Lett. 2010;17(10):1182-8.
13. Kocić I, Gruchała M, Petrusewicz J. Pretreatment of males guinea pigs by 17-β-estradiol induces hypersensitivity of β-adrenoceptors in electrically driven left atriaInt J Cardiol 2008; vol. 129, nr 1, s. 22-25.
14. I. Kocic´
    Modulators of Ion Channels Activated by Hypotonic Swelling in Cardiomyocytes: New Perspectives for Pharmacological Treatment of Life-Threatening Arrhythmias
    Curr. Med. Chem. – Cardiovascular & Hematological Agents, 2005; 13(4): 333-339
15. Kocić I, Hirano Y, Petrusewicz J, Hiraoka M.: Hypotonic stress enhances slope conductivity of ATP-sensitive K(+) channels activated pharmacologically. Int J Cardiol. 2007, 116, 423-424.
16. Kocic I, Gruchala M, Petrusewicz J.: Selective inhibition of pinacidil effects by estrogen in guinea pig heart.
    Int. J. Cardiol. 2006;110(1): 22-26
17. Ruczynski J, Konstanski Z, Cybal M, Petrusewicz J, Wojcikowski C, Rekowski P, Kaminska B.: Synthesis and biological properties of new chimeric galanin analogue GAL(1-13)-[Ala10,11]ET-1(6-21)-NH2. J. Physiol. Pharmacol. 2005; 56(2):273-85,
18. Umer A, Lugowska H, Sein-Anand J, Rekowski P, Ruczynski J, Petrusewicz J, Korolkiewicz RP.: The contractile effects of several substituted short analogues of porcine galanin in isolated rat jejunal and colonic smooth muscle strips. Pharmacol. Res. 2005; 52(4):283-9.
19. Kocic I, Hirano Y, Hiraoka M.: Hypotonic stress increases efficacy of rilmakalim, but not pinacidil, to activate ATP-sensitive K(+) current in guinea pig ventricular myocytes.
    J. Pharmacol. Sci. 2004;95(2):189-95
20. Korolkiewicz RP, Sein-Anand J, Ruczynski J, Rekowski P, Bieniaszewski L, Chodorowski Z, Petrusewicz J, Ujda M, Dabkowski J, Bitel M, Kato S, Takeuchi K.: The role and interactions of nitric oxide (NO), carbon monoxide (CO), and prostanoids in the pathogenesis of postoperative ileus in rats. J. Gastrointest. Surg. 2004;8(3):346-57.
21. Kocić I., Hirano Y., Kawano S., Hiraoka M.:
    Regional and frequency-dependent changes in action potentials and transient outward K⁺ currents in ventricular myocytes from J-2-K cardiomyopathic hamsters,
    Basic Res. Cardiol. 98, 367-379 (2003);
22. Kocić I., Gruchała M., Petrusewicz J.:
    Gender differences in effects of pinacidil but not diazoxide on heart automatism in the isolated guinea pig right atria,
    Pol. J. Pharmacol. 55, 419-424 (2003);
23. Siluk D., Kaliszan R., Haber P., Petrusewicz J., Brzozowski Z., Sut G.:
    Antiaggregatory activity of hypoglycaemic sulphonylureas,
    Diabetologia 45, 1034-1037 (2002);
24. Kocić I., Hirano Y., Hiraoka M.:
    Rate-dependent changes in action potential duration and membrane currents in hamster ventricular myocytes,
    Pflugers Archiv-Eur. J. Physiol. 443, 353-361 (2002);
25. Kocić I., Hirano Y., Hiraoka M.:
    Ionic basis for membrane potential changes induced by hypoosmotic stress in guinea-pig ventricular myocytes,
    Cardiovasc. Res. 51, 59-70 (2001);
26. Kocić I., Dworakowska D., Dworakowski R., Petrusewicz J.: CGP 41251, a new potential anticancer drug, improves contractility of rat isolated cardiac muscle subjected to hypoxia,
    J. Cardiovasc. Pharmacol. 37, 734-741 (2001);